Silence Therapeutics plc Balance Sheet
SLN|2 years of annual SEC 10-K data (FY2024-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 2 fiscal years. All figures from audited SEC 10-K filings.
Silence Therapeutics plc had $131M in total assets and $134M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -22.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 |
|---|---|---|
| Cash & Equivalents | $11.3M | $121.3M |
| Accounts Receivable | $0 | $972.0K |
| Current Assets | $118.7M | $187.4M |
| PP&E (Net) | $1.6M | $1.8M |
| Goodwill | $9.4M | $10.0M |
| Total Assets | $131.4M | $202.6M |
| Current Liabilities | $13.6M | $16.8M |
| Shareholders' Equity | $134.0M | $22.0M |